Home › Trial NCT07362602
Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies
- Trial IDNCT07362602
- StatusNot Yet Recruiting
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorThe 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
- Enrollment47
- Start date2026-01-26
- ConditionsHematological Malignancies
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.